Popit receives RCM certification

Popit continues to expand onto new markets. The latest market launch is happening in Australia, where Popit is now allowed to carry the local RCM mark.

“This certification opens the door for us in Australia. The market has significant potential and we have already partnered with a global pharmaceutical company operating on the Australian market. Deployment with the partner is set to start before the year-end”, says Teemu Piirainen, Popit’s CEO.

According to the Australian Bureau of Statistics in 2021 nearly half of Australians had at least one chronic condition requiring medication. At the same time 75% of all oral solid medications sold in Australia were packaged in blisters, making the market highly interesting for Popit.

With the clinically proven solution Popit will start to improve patient adherence in Australia. Get in touch if you want to learn more!